- The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial, potentially expanding the drug’s use beyond diabetes and weight loss. https://www.nejm.org/doi/full/10.1056/NEJMoa2306963 228 comments science